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Establishing lifelong infection and periodically shedding infectious progeny is a successful strategy em-
ployed by several persistent pathogens. In this issue of Cell Host & Microbe, Pan et al. (2014) demonstrate
that a cell-type-specific host microRNA can restrict gene expression and pathogenicity of herpes simplex
virus 1, thereby promoting long-term infection.In any prolonged war, de´tente, a long-
term relaxation of strained relations or
tensions between two nations, represents
a desirable outcome. This also applies
for the ongoing war between host and
pathogen, and particularly so for those
pathogens that have long coevolved with
their hosts. For a virus, establishing life-
long infection maximizes the opportunity
to spread to more hosts, thereby pro-
viding an evolutionary advantage. Viruses
have evolved a number of strategies
for persistent infection, and arguably the
most elegant is latency. Latent viruses
can undergo a lytic growth phase, involv-
ing replication of the viral genome, pro-
duction of progeny virus, lysis of cells,
infection of neighboring cells, and spread
to other organisms. During this phase,
the virus also infects cells within the
host where it is able to establish latency.
Latency results in drastically reduced
expression of most viral genes and elimi-
nates the production of infectious pro-
geny, allowing the virus to evade the
immune response. Periodically, the virus
reactivates from this quiescent state in
response to a variety of environmental
cues and re-enters the lytic phase of its
life cycle.
Members of the Herpesviridae family
could be considered the champions oflatent infection. There are several human
pathogens in this family, including
Epstein-Barr virus, human cytomegalo-
virus (HCMV), varicella-zoster virus, and
herpes simplex virus type 1 (HSV-1).
HSV-1 replicates primarily in epithelial
cells but establishes latency in neural
ganglia. During latency HSV-1 limits
gene expression to a single locus, the
non-protein-coding latency-associated
transcript (LAT), and coordinately reduces
lytic gene expression to near-undetect-
able levels. Both viral and host factors
are believed to be involved in establish-
ing and maintaining latency in neuronal
cells, but the mechanisms are still poorly
understood.
In one sense, the latent phase of the
viral life cycle is simply the repression
of the lytic phase. In herpesviruses, the
immediate early (IE) genes drive initiation
of the lytic phase. In HSV-1, the IE viral
protein ICP0 is required for reactivation
(Boutell and Everett, 2013) and for con-
trolling its own expression as well as other
IE genes that are critical to maintaining
latency. MicroRNA (miRNA)-mediated
silencing has garnered considerable
attention as a potential mechanism for
this regulation during latency (Cullen,
2011). Consistent with this hypothesis,
members of both the Herpesviridae andPolyomaviridae families encode autore-
gulatory miRNAs that control expression
of their lytic genes. For example, the LAT
locus of HSV-1 encodes several miRNAs
(Umbach et al., 2008; Jurak et al., 2011),
which have been linked to downregula-
tion of the IE genes ICP0 and ICP34.5
(Umbach et al., 2008). Thus, it is firmly
established that diverse viruses can use
miRNAs to regulate the expression of
their own genes—a potential factor in
both establishing and maintaining latent
infections.
miRNA regulation is prevalent in multi-
cellular eukaryotes and, directly or indi-
rectly, likely regulates all cellular path-
ways. miRNAs are central components
of the RNA-induced silencing complex
(RISC), targeting it to messenger RNAs
(mRNAs) via base pairing. Numerous
miRNAs have cell-type-specific expres-
sion, making them attractive candidates
as host factors involved in circumstan-
tial regulation of lytic gene expression.
Indeed, there are examples of host
miRNAs affecting the cell-type-specific
gene expression of diverse viruses (Gu-
nasekharan and Laimins, 2013; Tro-
baugh et al., 2014; Jopling et al., 2005).
Despite what is known, many questions
remain regarding the extent to which
host miRNAs are coopted ore 15, April 9, 2014 ª2014 Elsevier Inc. 395
Figure 1. An Endogenous HostmiRNA, with Enriched Expression in Latency-Permissive Cell
Types, Cooperates with Viral and Other Host Factors in Both the Establishment and
Maintenance of Latency by Repressing Viral Immediate-Early Genes
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on latency.
An article in this issue of Cell Host &
Microbe explores the effect of a host
miRNA on the expression of viral gene
products, and the consequence of this
regulation on the biology and pathology
of HSV-1 (Pan et al., 2014; Figure 1). Spe-
cifically, Pan and colleagues report that
human miR-138, previously identified as
a potential tumor suppressor, negatively
regulates HSV-1 ICP0 and, in doing so,
promotes latency. The authors computa-
tionally identify miR-138 binding sites
in the 30 UTR of the ICP0 mRNA and
demonstrate that exogenous expression
of miR-138 significantly reduces expres-
sion of ICP0 from a plasmid containing
both its open reading frame and 30 UTR.
The effect of miR-138 on ICP0 levels
is sequence specific, as mutation of
the binding site abolishes regulation. To
confirm that RISC binds the ICP0 tran-
script, the authors infected cells stably
expressing exogenous miR-138, then,
using crosslinking followed by high-
throughput sequencing analysis, identi-
fied clusters of reads that map to the
two predicted binding sites for miR-138
in the 30 UTR of ICP0. With these tech-
niques, the authors convincingly demon-
strate that miR-138 can regulate expres-
sion of the ICP0 in a virus-independent
context.
Next, the authors focused on miR-
138 activity during HSV-1 infection of
cultured cells. Treating cells expressing
a mimic of miR-138 with an antisense in-
hibitor of miR-138 resulted in higher ICP0
and IE expression than treating with a396 Cell Host & Microbe 15, April 9, 2014 ª2control antisense inhibitor. Additionally,
infection of neuronal cells (that naturally
express miR-138) with a mutant virus
containing nucleotide substitutions in
both miR-138 docking sites of the ICP0
30 UTR results in significantly increased
expression of ICP0 and other IE tran-
scripts. However, perhaps unexpectedly,
growth of this mutant virus was unaf-
fected. These results demonstrate that
the endogenous host miRNA, miR-138,
can affect the level of viral gene expres-
sion during HSV-1 infection in cultured
cells.
To address the biological relevance of
miR-138-mediated regulation of ICP0,
the authors used a murine model.
Following inoculation of the cornea, viral
replication at the eye and in the site of
latency, the trigeminal ganglion (TG),
was reported. Virus yield at both sites
was unaffected by mutation of the miR-
138 binding sites and decreased with
similar kinetics in the TG, presumably re-
flecting similar onset of latency. However,
at 7 days postinfection, mutant-virus-
infected cells had elevated levels of
ICP0 and other lytic transcripts. Yet, these
mice had wild-type levels of LAT expres-
sion and viral genome levels (in the TG),
suggesting that the elevated lytic tran-
script levels were not significantly altering
viral replication. These results demon-
strate that host miRNA miR-138 regulates
lytic gene expression in vivo but, at
least under these conditions, with unde-
tectable consequence to virus replication.
Remarkably, there was an almost 4-fold
increase in mortality of mice by 32 days
postinfection with the mutant virus014 Elsevier Inc.(relative to wild-type). One possible ex-
planation for the higher mortality rate
associated with the mutant virus could
be decreased maintenance of latency
accompanying increased lytic virus gene
expression. However, analysis of the TG
of the mice at 32 days postinfection
revealed no significant increase in the
level of lytic transcripts. Despite the
mechanistic basis remaining unclear,
these data identify a fascinating role for
a host miRNA in preventing pathogenesis
of a virus.
Altogether, this work shows that HSV-1
utilizes a host miRNA to regulate lytic
gene expression in cell culture and in vivo.
Given the enriched expression ofmiR-138
in neuronal cells, and the restriction of
HSV-1 latency to some types of ganglia,
the authors’ model of miR-138 as a
direct neuronal latency restriction factor
seems likely. However, important ques-
tions remain regarding this model. For
example, how can miR-138 promote
latency without altering the amount of
virus produced during infection of mice?
Why are the kinetics of the onset of
latency unaffected for the mutant virus?
The use of both host and viral miRNAs
to regulate ICP0 clearly underscores its
importance but begs the question of
what advantage is conveyed by such
multi-miRNA regulation. One possibility
is that the host miRNA synergizes with
or nucleates viral miRNA regulation.
What is clear is that the reduced patho-
genicity associated with miR-138-medi-
ated regulation at least indirectly allows
for increased latency within the popu-
lation, since dead hosts are not useful
latent reservoirs.
Given the importance of cell-type-
specific control of viral gene expression
during persistent infection, it is not
surprising that other viruses use host
miRNAs for similar purposes. Notably,
O’Connor and colleagues recently
demonstrated that an IE gene from the
distantly related HCMV is targeted by
miR-200, a miRNA enriched in the
CD34+ myeloid lineage that HCMV
latently infects (O’Connor et al., 2014).
Furthermore, overexpression of miR-200
decreases lytic gene expression and fa-
vors latency, while infecting cells with a
binding site mutant virus leads to
increased viral replication. The preva-
lence of host miRNA-mediated regulation
in diverse viruses suggests intriguing
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by many of the stress signals associated
with induction of lytic replication, making
it possible for viruses to use RISC activity
as a barometer for stress (Seo et al.,
2013). In this model, alleviating miRNA-
mediated regulation would trigger a feed-
forward transcriptional cascade resulting
in increased lytic replication. Alterna-
tively, but not mutually exclusive, miRNA
regulation may slow lytic replication,
allowing chromatin modifications to
establish latency. Several examples of
host miRNAs directly regulating virus
gene expression or replication are known
(Gunasekharan and Laimins, 2013; Tro-
baugh et al., 2014; Jopling et al., 2005;
O’Connor et al., 2014), and likely many
others await discovery. Undoubtedly,
the work by Pan et al. makes an important
contribution to this growing field andsuggests that other pathogens may also
utilize host miRNAs to promote modus
vivendi, representing an arrangement
that would help host and pathogen
coexist.
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Pattern recognition receptors (PRR) promote pathogen eradication and shape adaptive immunity. Although
evidence suggests PRRs can antagonize each other, few detailed mechanisms are known. Wevers et al.
(2014) uncover a mechanism of PRR antagonism where fungal-induced Mincle signaling suppresses IL-12
transcription induced by other PRRs and thereby abates antifungal immunity.Innate recognition of pathogens is medi-
ated by multiple pattern recognition
receptors (PRRs) that can be broadly
classified as secreted, cytosolic, or trans-
membrane. These receptors are germline
encoded, recognize a variety of microbial
moieties, promote pathogen clearance by
activating innate cells, and crucially shape
adaptive immunity.
Transmembrane PRRs include Toll-like
receptors (TLRs) and C-type lectins
(CLRs). Although TLRs are the best
known and studied, there is growing
appreciation of CLRs as crucial mediators
of antimicrobial immunity, especially inresponse to fungi (Hardison and Brown,
2012). Similar to TLRs, members of the
CLR family of receptors have been found
to link innate recognition of fungal patho-
gens to the activation of adaptive immu-
nity. These include Dectin-1, Dectin-2,
and Mincle, which promote antifungal
effector mechanisms in innate cells and
shape adaptive immunity by promoting
CD4 T cell differentiation toward Th1 and
Th17 pathways, which largely mediate
fungal clearance (Hardison and Brown,
2012). These CLRs can mediate all the
prototypical PRR functions independently
of TLRs. Moreover, previous studies havesuggested that CLR-mediated signals
may modulate the activities of TLRs via
synergistic or antagonistic interactions
(Hardison and Brown, 2012; O’Neill,
2008).
CLRs play crucial roles in defense
against pathogens and recognize a vari-
ety of carbohydrate moieties (Hardison
and Brown, 2012). Ligand binding to
CLRs leads to the activation of NF-kB
via a Syk/CARD9 signaling module. Syk
kinase is recruited to immunoreceptor
tyrosine (Y)-based activation motifs
(ITAM) within CLRs and activated directly
or indirectly. While Dectin-1 directlye 15, April 9, 2014 ª2014 Elsevier Inc. 397
